Contact
Please use this form to send email to PR contact of this press release:
Basilea announces CHF 5 million milestone payment from Asahi Kasei Pharma for antifungal Cresemba® (isavuconazole) in Japan
TO:
Please use this form to send email to PR contact of this press release:
Basilea announces CHF 5 million milestone payment from Asahi Kasei Pharma for antifungal Cresemba® (isavuconazole) in Japan
TO: